Correlation Between Aeglea Bio and Altamira Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aeglea Bio and Altamira Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aeglea Bio and Altamira Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aeglea Bio Therapeutics and Altamira Therapeutics, you can compare the effects of market volatilities on Aeglea Bio and Altamira Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aeglea Bio with a short position of Altamira Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aeglea Bio and Altamira Therapeutics.

Diversification Opportunities for Aeglea Bio and Altamira Therapeutics

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Aeglea and Altamira is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Aeglea Bio Therapeutics and Altamira Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Altamira Therapeutics and Aeglea Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aeglea Bio Therapeutics are associated (or correlated) with Altamira Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Altamira Therapeutics has no effect on the direction of Aeglea Bio i.e., Aeglea Bio and Altamira Therapeutics go up and down completely randomly.

Pair Corralation between Aeglea Bio and Altamira Therapeutics

If you would invest (100.00) in Altamira Therapeutics on December 2, 2024 and sell it today you would earn a total of  100.00  from holding Altamira Therapeutics or generate -100.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Aeglea Bio Therapeutics  vs.  Altamira Therapeutics

 Performance 
       Timeline  
Aeglea Bio Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Aeglea Bio Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound essential indicators, Aeglea Bio is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
Altamira Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Altamira Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Altamira Therapeutics is not utilizing all of its potentials. The newest stock price disarray, may contribute to short-term losses for the investors.

Aeglea Bio and Altamira Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aeglea Bio and Altamira Therapeutics

The main advantage of trading using opposite Aeglea Bio and Altamira Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aeglea Bio position performs unexpectedly, Altamira Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Altamira Therapeutics will offset losses from the drop in Altamira Therapeutics' long position.
The idea behind Aeglea Bio Therapeutics and Altamira Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance